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Background: This study aimed to identify characteristic representative genes through a comparative analysis of
gene expression profiles in the blood and saliva of chronic periodontitis (CP) and refractory periodontitis (RP)
patients to provide new treatment strategies that may be helpful in the treatment of different forms of periodontitis.
Methods: GSE43525 was downloaded from Gene Expression Omnibus. In the dataset, thirteen samples were from
blood including 4 controls, 4 CP and 5 RP samples, and ten samples were from saliva including 3 controls, 4 CP and 3
RP samples. After comparing the CP and RP samples, differentially expressed genes (DEGs) between these two types of
periodontitis in the blood and saliva samples were identified by an LIMMA package. Then, functional and pathway
enrichment analyses were performed by DAVID and KOBAS, respectively. The significantly associated miRNAs in CP and
RP were searched by WebGestalt.
Results: In total, 213 DEGs in CP and 45 DEGs in RP were identified. Functional enrichment showed that the DEGs of
CP were mainly enriched in ribosome and regulation of apoptosis-related pathways in blood as well as saliva, while the
DEGs of RP were significantly enriched in immune responses and response to organic substance-related pathways.
Several miRNAs, such as miR-381 and miR-494, were identified as being closely associated with CP. In addition, CD24,
EST1, MTSS1, ING3, CCND2 and SYNE2 might be potential targets for diagnosis and treatment of CP.
Conclusion: The identified DEGs and miRNAs might be potential targets for the treatment of chronic and refractory
periodontitis.
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MiRNABackground
In recent years, periodontal diseases have become a
major health problem worldwide. Periodontal diseases
are infectious diseases caused by bacteria in the dental
plaque [1]. Chronic periodontitis (CP) is an inflamma-
tory destruction of tooth supporting structures that, if* Correspondence: honghehhe@163.com
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nearly 50 % of the adult population and 60 % of the aged
population globally [4]. CP is the most prevalent and de-
structive disease in adults [5]. In most periodontitis
cases, therapeutic success is obtained for long periods of
time [6]; however, a small proportion of treated patients,
referred to as refractory periodontitis (RP) patients, do
not respond well to properly performed conventional
therapy and continue to show loss of periodontal attach-
ment [7, 8]. The existence of specific pathogenic micro-
biotas may contribute to RP [9]. RP patients are very
heterogeneous in terms of their clinical, microbiological
and immunological characteristics [10].
CP is found in the presence of subgingival calculus and
local factors [11]. The pathogenesis of CP is multifactorialis distributed under the terms of the Creative Commons Attribution 4.0
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Fig. 1 The research analysis process of blood and saliva tissues
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environmental, immunologic and genetic factors [12].
There is growing evidence that polymorphisms in inter-
leukin 1 (IL1), IL6, IL10, etc. may be associated with CP in
certain populations. Several cytokines, including tumour-
necrosis factor-α (TNF-α), IL1, IL6, IL8, intercellular ad-
hesion molecule-1 (ICAM-1), monocyte chemoattractant
protein-1 (MCP-1), and granulocyte-macrophage colony-
stimulating factor (GM-CSF), play important roles in the
development process of periodontitis. The nuclear factor-
κB (NF-κB) signalling pathway is involved in parts of the
immune response, such as antigen presentation, immune
balance and lymphocyte activation, and is significant in
periodontitis [13]. CP is initiated and maintained in the
first line by complex poly-microbial infection, and the in-
nate susceptibility of the patient is now an accepted crit-
ical factor that will determine the destructive character of
the disease [14]. An intraradicular infection persisting in
the complex apical root canal system and extraradicular
infection presenting in the form of periapical actinomyco-
sis can lead to RP [15]. With high incidence and prevalent
characteristics, the diagnosis and treatment of CP and RP
has undoubtedly been a challenge for both clinical investi-
gators and clinicians.
The aim of present study was to compare and analyse
these two types of periodontitis at the genetic level in
blood and saliva samples and to explore the possible
mechanism of periodontitis. Biological microarray ana-
lysis was used to analyse the gene expression profile of
CP and RP in different biological fluids with the aim of
providing additional treatments and the ability to better
distinguish periodontitis.
Methods
Microarray data
The research analysis process is shown in Fig. 1 The
gene expression profile of GSE43525 [16] was down-
loaded from Gene Expression Omnibus (GEO), which
was based on the platform of the HumanHT-12 V4.0 ex-
pression beadchip. Each set of expression profiling data,
which is submitted to the GEO database mainly by la-
boratories all around the world, includes platform infor-
mation, series information and sample information [17].
A total of 13 samples (including 4 control samples, 4 CP
samples and 5 RP samples) were obtained from the
blood, and 10 samples (including 3 control samples, 4
CP samples and 3 RP samples) were from the saliva ac-
cording to the website information (http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE43525). These samples
were chosen from patients of different sexes and ages. All
of the patients were from the Faculty of Dentistry, Univer-
sity of Toronto, Toronto, ON and provided informed con-
sent. In additon, GSE43525 was deposited by Lakschevitz
et al. whose study was approved by the Office of ResearchEthics (ORE) at the University of Toronto (Protocol #
25698) [16].
Comparative analysis of chronic and refractory
periodontitis samples from blood and saliva
In accordance with the descriptions and characteristics
of the original samples, the blood and saliva samples
from the CP and RP patients were used for gene expres-
sion profile analysis.
Data preprocessing and identification of differentially
expressed genes (DEGs)
The probe-level data were converted into the expression
measures. For each sample, the expression values of all
probes for a given gene were reduced to a single value
by taking the average expression value and then log2-
transformation was conducted [18]. The linear model of
microarray data (LIMMA) package in R [19] was used to
identify the DEGs of CP and RP in the blood and saliva
compared with normal controls. The p-value < 0.05 and
|log fold change (FC)| > 1 were used as the cut-off
criteria.
Functional enrichment analysis of DEGs
Gene enrichment analysis is an analytical strategy using
a set of similar or related genes as a whole by calculating
the overall significance of changes in gene expression to
identify whether the biological function or properties
change. This strategy could greatly reduce the dimension
of data analysis and makes the analysis process closer to
biological problems, therefore this method is widely used
in microarray technology [20]. Currently, there are many
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tion. Among them, Database for Annotation, Visualiza-
tion and Integrated Discovery (DAVID) is the most
popular [21]. DAVID provides a comprehensive set of
functional annotation tools for investigators to under-
stand the biological meaning behind a large list of genes.
We performed a Gene Ontology (GO) enrichment
analysis in terms of biological progress (BP). The false
discovery rate (FDR) < 0.05 was used as the cut-off
criterion.
Pathway analysis of DEGs
To better understand and further study the biological
functions, the KEGG Orthology Based Annotation Sys-
tem (KOBAS) [22] was used to conduct the pathway
annotation and enrichment analysis based on a hyper-
geometric distribution. The p-value < 0.05 was used as
the cut-off criterion.
Searching for significantly associated microRNAs
MicroRNA (miRNA) broadly participate in many bio-
logical processes and can be used as a biomarker for the
diagnosis of a variety of diseases [23, 24]. We used the
WEB-based Gene Set Analysis Toolkit (WebGestalt) to
calculate the association between DEGs and miRNAs in
CP and RP [25, 26]. The p-value < 0.05 was used as the
cut-off criterion.
Results
Identification of DEGs
After preprocessing the microarray data, the LIMMA
package was used to screen the DEGs. A total of 213
DEGs in CP (including 76 up-regulated and 14 down-
regulated genes in the blood as well as 94 up-regulated
and 29 down-regulated genes in the saliva) and 45 DEGs
in RP (including 13 up-regulated and 7 down-regulatedFig. 2 a: Up-regulated and down-regulated genes in the blood and saliva of
genes in the blood and saliva of patients with refractory periodontitis. black cgenes in the blood, as well as 10 up-regulated and 15
down-regulated genes in the saliva) were identified (Fig. 2).
Functional enrichment analysis of DEGs
To study the functions of DEGs in CP and RP in blood
and saliva, the functional enrichment analysis of all these
DEGs were performed by DAVID. The results showed
that DEGs in the blood of CP patients were involved in
translation-related BP terms (Table 1a). Meanwhile, the
DEGs in the blood of RP patients were mainly enriched
in immune response processes (Table 1b). Moreover, the
DEGs in the saliva of CP patients were mainly involved
in the regulation of apoptosis and cell death (Table 1c).
In addition, the DEGs in the saliva of RP patients were
mainly enriched in genes responsive to organic sub-
stances and bacterium (Table 1d).
Pathway analysis of DEGs
To further understand the involved pathways of each set
of DEGs, a pathway enrichment analysis was further per-
formed. A total of 10 pathways were enriched for the
DEGs (Table 2). The DEGs of the blood of CP patients
were enriched in two pathways, the most significant be-
ing ribosome (p = 2.24E-10), which involved 11 DEGs.
The DEGs in the blood of RP patients were mainly in-
volved in five pathways, the most significant of which
were cell adhesion molecules (CAMs). Meanwhile, the
DEGs in the saliva of CP patients were enriched in the
pathway of antigen processing and presentation. The
DEGs in the saliva of RP patients were involved in tryp-
tophan metabolism and aldosterone-regulated sodium
reabsorption.
MiRNA-target gene analysis
WebGestalt was used to analyse the related miRNAs in
CP and RP. Table 3 shows the relationship betweenpatients with chronic periodontitis; b: Up-regulated and down-regulated
olour: down-regulated genes; grey colour: up-regulated genes
Table 1 Gene Ontology enrichment analysis of differentially
expressed genes of chronic and refractory in blood and saliva
a) Blood-chronic
Term Count P-value
GO:0006414 ~ translational elongation 11 8.07E-11
GO:0006412 ~ translation 13 9.52E-08
GO:0006968 ~ cellular defense response 6 1.42E-05
b) Blood-refractory
Term Count P-value
GO:0006955 ~ immune response 4 3.16E-02
c) Saliva-chronic
Term Count P-value
GO:0042981 ~ regulation of apoptosis 12 2.64E-03
GO:0043067 ~ regulation of programmed cell death 12 2.85E-03
GO:0010941 ~ regulation of cell death 12 2.93E-03
GO:0008202 ~ steroid metabolic process 6 3.90E-03
d) Saliva-refractory
Term Count P-value
GO:0010033 ~ response to organic substance 5 8.71E-03
GO:0009617 ~ response to bacterium 3 2.13E-02
GO:0019439 ~ aromatic compound catabolic
process
2 2.34E-02
GO:0008286 ~ insulin receptor signaling pathway 2 4.29E-02
GO:0045787 ~ positive regulation of cell cycle 2 6.54E-02
Table 2 The significanlty enriched pathways by differentially
expressed genes
a) Blood-chronic
Pathway P-value
hsa03010:Ribosome 2.24E-10
hsa05332:Graft-versus-host disease 3.06E-02
b) Blood-refractory
Pathway P-value
hsa04514:Cell adhesion molecules (CAMs) 6.35E-03
hsa05330:Allograft rejection 3.49E-02
hsa05332:Graft-versus-host disease 3.78E-02
hsa04940:Type I diabetes mellitus 4.06E-02
hsa05320:Autoimmune thyroid disease 4.92E-02
c) Saliva-chronic
Pathway P-value
hsa04612:Antigen processing and presentation 1.24E-02
d) Saliva-refractory
Pathway P-value
hsa00380:Tryptophan metabolism 4.63E-02
hsa04960:Aldosterone-regulated sodium reabsorption 4.74E-02
Table 3 Target genes and their corresponding miRNAs in
different groups
a) Blood chronic
MiRNA ID P-value Target genes
hsa_CTTGTAT,MIR-381 DB_ID:731 4.20E-02 ETS1, MTSS1
hsa_TGTGTGA,MIR-377 DB_ID:845 4.07E-02 CD24, ETS1
hsa_CAGCAGG,MIR-370 DB_ID:682 2.73E-02 SLAMF6, MTSS1
hsa_ATACTGT,MIR-144 DB_ID:702 4.47E-02 ETS1, ALDH1A3
b) Saliva chronic
MiRNA ID P-value Target genes
hsa_ATGTTTC,MIR-494 DB_ID:782 4.80E-03 ING3, CCND2, SYNE2
hsa_ACCATTT,MIR-522 DB_ID:749 4.80E-03 ING3, YWHAZ, CCND2
hsa_AGGTGCA,MIR-500 DB_ID:827 1.64E-02 CREB1, POFUT1
hsa_AGGGCAG,MIR-18A DB_ID:668 3.35E-02 YWHAZ, CREB1
hsa_TAATGTG,MIR-323 DB_ID:724 4.38E-02 CREB1, TGFA
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RP samples; however, there were 4 and 5 DEGs related
to the miRNAs in the blood and saliva of CP patients,
respectively. We found that cluster of differentiation 24
(CD24), esterase 1 (EST1), and metastasis suppressor 1
(MTSS1) were target genes for CP in blood, while, in-
hibitor of growth family member 3 (ING3), cyclin D2
(CCND2) and synaptic nuclear envelope protein 2 (SYNE2)
were target genes for CP in saliva. The most significantly
related miRNAs were miR-381 (which targets ETS1 and
MTSS1) and miR-494 (which targets ING3, CCND2 and
SYNE2).
Discussion
Periodontitis is a multifactorial infectious inflammatory
condition characterized by a destructive inflammatory
process affecting the supporting tissues of the tooth and
resulting in alveolar bone resumption, periodontal pocket
formation and eventually tooth loss [27]. CP is a typical
disease that has a relatively mild phenotype and a slow
progressing and chronic nature [28]. Functional enrich-
ment showed that DEGs of RP were significantly enriched
in immune responses. Additionally, persistent host inflam-
matory immune responses against pathogens results in
the destruction of soft and mineralized periodontal tissues[29]. According to our results, functional level analysis
showed that these two types of periodontitis could cause
significant expression changes in the immune defence-
related genes in the blood and saliva. As soon as the path-
ogens invade the periodontal tissue, the immune system
uses a variety of methods including humeral immunity
and cellular immunity to avoid the occurrence of peri-
odontitis [30]. In our study, we obtained DEGs and their
corresponding miRNAs in the blood and saliva of CP pa-
tients. Through searching for significantly associated
microRNAs for the DEGs, the target genes including
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found. MiR-381 (which targets ETS1 and MTSS1) and
miR-494 (which targets ING3, CCND2 and SYNE2) were
the most significantly related miRNA in the blood and sal-
iva. These miRNAs might function in CP by regulating
their target genes.
CD24 was found to be highly expressed in periodon-
titis. The consistent high expression of CD24 has been
reported in the epithelial attachment to the tooth and in
the migrating epithelium of the periodontitis lesion, and
titres of serum antibodies auto-reactive with CD24 pep-
tide correlates with the remission of periodontal disease
[31]. Functional analysis revealed that MTSS1, which
was initially described as a gene missing in invasive blad-
der cancer cell lines, was an actin binding protein in-
volved in the regulation of actin cytoskeleton dynamics.
MTSS1 is shown to be sonic hedgehog (Shh) signaling
dependent and synergize with the effects of Gli tran-
scription factors [32]. ING3 is a subunit of the nucleo-
some acetyltransferase of histone 4 (NuA4) complex,
which activates gene expression. ING3 is ubiquitously
expressed in mammalian tissues and governs transcrip-
tional regulation and cell cycle control [33]. Although
reports on their roles in the progression of periodontitis
are rare, we speculated that these genes might play key
roles in periodontitis. EST1, MTSS1, ING3, CCND2 and
SYNE2, as well as their corresponding miRNAs, might
be potential therapeutic targets for periodontitis. The
serum antibody titres were increased in all patients
with periodontitis to some degree [34]. The genetic
susceptibility factors of periodontitis and quick identi-
fication of susceptible periodontitis patients will con-
tribute to the prevention and treatment of periodontal
disease.Conclusions
In summary, our data provides a comprehensive bioinfor-
matics analysis of DEGs in the blood and saliva of CP and
RP patients. A total of 213 DEGs in CP and 45 DEGs in
RP were identified. CD24, EST1, MTSS1, ING3, CCND2
and SYNE2 may have the potential to be used as targets
for periodontitis diagnosis and treatment.; however, more
research is still needed to validate our findings.Abbreviations
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